Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
48 /100
MEDIUM RISK
Score updated Aug 28, 2026

MIST — Milestone Pharmaceuticals Inc. Dilution Risk Tracker

Track MIST dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MIST — Get alerts when the score changes →

As of August 28, 2026, Milestone Pharmaceuticals Inc. (MIST) has a DilutionWatch DilutionScore of 48/100, rated MEDIUM dilution risk. Milestone Pharmaceuticals Inc. has a market capitalization of $176.79M, 124.50M shares outstanding, 86 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
100
⚠️ Warrant Exposure
40
🔄 Convertible Debt
60

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 29%
🔁 Convertible Conversion model 40%
• Significant convertible debt: 28% potential dilution
• Elevated convertible risk (60/100)
🔄 Reverse Split model est. 30%
• 50-day avg $1.67 approaching $1 threshold
🔔 Track MIST — Get forecast alerts →

Market Data

Market Cap$176.79M
Shares Outstanding124.50M
Float14.07M
Cash$170.61M
Debt$59.21M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 30.9% shares (2026Q1 vs prior)
86 institutional holders · 37.04M shares
#1 RTW INVESTMENTS, LP 6.33M shares
#2 MORGAN STANLEY 4.48M shares
#3 Propel Bio Management, LLC 4.12M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest15.69M
Days to Cover12.7
% of Float111.5%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2023-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual MIST Dilution Snapshot

Milestone Pharmaceuticals Inc. (MIST) has a DilutionScore of 48/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track MIST Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MIST — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for MIST
MIST FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.